免疫检查点抑制剂相关心肌炎研究进展

Research progress of immune checkpoint inhibitor related myocarditis

本文介绍了FDA批准的肿瘤免疫治疗中的免疫检查点抑制剂,并简述了免疫检查点抑制剂的心脏毒性,尤其是免疫相关的心肌炎的临床特征、可能发病机制及治疗和管理。

The immuno-checkpoint inhibitors approved by FDA in tumor immunotherapy were introduced in this paper.The cardiotoxicity of immuno-checkpoint inhibitors,especially the clinical features,possible pathogenesis,treatment and management of immuno-related myocarditis,was briefly described in this paper.